Hjem › Type 1-diabetes › New York › New York City
Kliniske studier for Type 1-diabetes i New York City, NY
15 studier for Type 1-diabetes søker deltakere på steder i og rundt New York City (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
App-Based Certified Diabetes Education Therapy (AB-CDE)
Rekrutterer
- Mount Sinai School of Medicine, New York
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
RekruttererFase 3
- Endocrine Associates of West Village- Site Number : 8400064, New York
- Columbia University Irving Medical Center- Site Number : 8400009, New York
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
RekruttererFase 1/2
- Hassenfield Children's Hospital, New York
- NYU Langone Diabetes & Endocrine Associates, New York
Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG
RekruttererFase 2
- Columbia University, New York
Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
RekruttererFase 2
- Columbia University, New York
HLA Demographics Study in Adults With Type 1 Diabetes
RekruttererObservasjonsstudie
- Icahn School of Medicine at Mount Sinai, New York
Long-Term Outcomes of Teplizumab in Routine Clinical Care
RekruttererObservasjonsstudie
- Investigational Site Number: 8400001, New York
APP-MNT: App-Enhanced Medical Nutrition Therapy on Glycemic Outcomes and Quality of Life
Rekrutterer
- Weill Cornell Medicine, New York
A Study of GNTI-122 in Adults Recently Diagnosed With T1D
RekruttererFase 1
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University, New York
Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study
RekruttererObservasjonsstudie
- Mount Sinai, New York
Kidney Precision Medicine Project
RekruttererObservasjonsstudie
- Mount Sinai, New York
Cholesterol Lowering and Residual Risk in Diabetes, Type 1
RekruttererFase 4
- New York VA Hospital, New York
- NYC Health + Hospitals/Bellevue, New York
- NYU Langone Health, New York
- og 1 flere
TrialNet Pathway to Prevention of T1D
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Columbia University, New York
NYSCF Scientific Discovery Biobank
RekruttererObservasjonsstudie
- New York Stem Cell Foundation Research Institute, New York
PRenatal and Obstetric Maternal Exposures and ISlet Autoantibodies in Early Life
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Mt Sinai, New York
Type 1-diabetes-studier i andre byer
- Aurora, CO23 studier
- Boston, MA21 studier
- Seattle, WA18 studier
- Chicago, IL16 studier
- New Haven, CT15 studier
- Indianapolis, IN14 studier
- San Francisco, CA14 studier
- Miami, FL13 studier
- Gainesville, FL12 studier
- Atlanta, GA11 studier
- Philadelphia, PA11 studier
- Minneapolis, MN10 studier
Andre studier i New York City
- Brystkreft136 studier
- Ikke-småcellet lungekreft121 studier
- Kreft (alle typer)109 studier
- Prostatakreft103 studier
- Metastatisk kreft93 studier
- Kolorektal kreft78 studier
- Eggstokkreft69 studier
- Lungekreft60 studier
- Multipelt myelom60 studier
- Pankreaskreft60 studier
- Endometriekreft52 studier
- Akut myelogen leukemi51 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.